LAVENTATUG TIVEDOTIN

UNII:	NUK386L57F
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	LAVENTATUG TIVEDOTIN
GSRS Full Record:	NUK386L57F i

3009829-96-0
Immunoglobulin G1, anti-(human zinc transporter ZIP6) (human-Mus musculus monoclonal BRY812 γ1-chain), complex with human-Mus musculus monoclonal BRY812 κ-chain, dimer, 219′′,223,229,232-tetrakis(thioether) with N-methyl-N-[[[4-[[N-(2-mercaptoacetyl)-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide
Laventatug Tivedotin
laventatug tivedotin [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LAVENTATUG TIVEDOTIN

Synonyms and Mappings

Resources